Latest period
$263.76M
YoY change
+4.9%
5Y CAGR
—
Peak year (2025)
$176.48M
Latest annual
$176.48M
Cash on Hand history chart for Alto Neuroscience (ANRO) from 2021 to 2025
Latest: $176.48M
Cash on Hand growth chart for Alto Neuroscience (ANRO) from 2021 to 2025
Latest: +4.9%
Cash on Hand history table for Alto Neuroscience (ANRO) from 2021 to 2025
| 2025 | $176.48M | +4.9% | +$8.26M | ||
| 2024 | $168.23M | +103.8% | +$85.68M | ||
| 2023 | $82.55M | +70.8% | +$34.20M | ||
| 2022 | $48.34M | +88.1% | +$22.64M | ||
| 2021 | $25.70M | — | — |
- 2025$176.48M+4.9%
- 2024$168.23M+103.8%
- 2023$82.55M+70.8%
- 2022$48.34M+88.1%
- 2021$25.70M—
Cash on Hand values are taken from Alto Neuroscience's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Cash on Hand at Alto Neuroscience (ANRO)
According to Alto Neuroscience's latest reported financial statements, the company's latest reported cash and short-term investments is $263.76M. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for net leverage and total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual cash and short-term investments for Alto Neuroscience (ANRO) came in at $176.48M – edged up 4.9% year-over-year.
Across the available history, cash and short-term investments reached its high of $176.48M in 2025 and its low of $25.70M in 2021.
Alto Neuroscience Cash on Hand by Year
Alto Neuroscience Cash on Hand 2025: $176.48M
2025's cash and short-term investments for Alto Neuroscience came in at $176.48M, edged up 4.9% from 2024. This figure represents the highest annual value in the available history.
Alto Neuroscience Cash on Hand 2024: $168.23M
Alto Neuroscience posted cash and short-term investments of $168.23M in 2024, surged 103.8% from 2023.
Alto Neuroscience Cash on Hand 2023: $82.55M
In 2023, Alto Neuroscience reported cash and short-term investments of $82.55M, surged 70.8% from 2022.
Alto Neuroscience Cash on Hand 2022: $48.34M
Alto Neuroscience cash and short-term investments in 2022 was $48.34M, surged 88.1% from 2021.
Alto Neuroscience Cash on Hand 2021: $25.70M
Alto Neuroscience cash and short-term investments in 2021 was $25.70M.
See more financial history for Alto Neuroscience (ANRO).
Sector peers by Cash on Hand
Healthcare peers of Alto Neuroscience (ANRO), ranked by their latest cash and short-term investments
| $28.12B | |
| $20.10B | |
| $14.56B | |
| $9.13B | |
| $7.27B | |
| $5.74B | |
| $5.26B | |
| $4.24B |
- $28.12B
- $20.10B
- $14.56B
- $9.13B
- $7.27B
- $5.74B
- $5.26B
- $4.24B
Frequently asked questions
Alto Neuroscience (ANRO) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation